Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance

By SharpBrains | June 27, 2018

___ Dreem Announces $35 Mil­lion Financ­ing from lead investors John­son & John­son Inno­va­tion and Bpifrance (press release): “Dreem, a neu­rotech­nol­o­gy com­pa­ny, today announced the clos­ing of a new round of fund­ing, rais­ing $35 mil­lion USD to rapid­ly accel­er­ate prod­uct devel­op­ment, invest in strate­gic research and devel­op­ment, and advance the future of sleep tech­nol­o­gy. Last year,…

Read More

September update: Revolutions in neurotechnology will soon influence every aspect of human life

By SharpBrains | September 30, 2015

Time for Sharp­Brains’ Sep­tem­ber e‑newsletter, wrap­ping up this month’s key brain-relat­ed news. Our brain is at the core of every­thing we do, from the every-day deci­sions we make to the epic emo­tions we feel when we fall in love. And neurotechnologies–especially those that, being dig­i­tal, are emi­nently scal­able, and that, being non-inva­­sive, pose few if any negative…

Read More

Cogniciti and Johnson & Johnson Innovation partner to improve cognitive screenings for early identification of dementia

By SharpBrains | September 16, 2015

Cog­nic­i­ti Announces Col­lab­o­ra­tion with John­son & John­son Inno­va­tion to Eval­u­ate Online Cog­ni­tive Screen­ing to Iden­ti­fy Indi­vid­u­als at Risk for Demen­tia (Bay­crest press release): “Cog­nic­i­ti Inc., the Toron­­to-based devel­op­er of a 20-minute online cog­ni­tive test for adults con­cerned about mem­o­ry changes, today announced a col­lab­o­ra­tion agree­ment with Janssen Phar­ma­ceu­ti­cals, Inc. to eval­u­ate online screen­ing strate­gies for…

Read More